Phaarmasia Share Price

  • 35.980.65 (1.83%)
  • Volume: 611
BSE
  • Closed
  • Last Updated On: 17 Oct, 2025, 03:44 PM IST
High: "NaN",Open: "NaN",Low: "NaN",
Loading...
Phaarmasia Share Price
  • 35.980.65 (1.83%)
  • Volume: 611
Advertisment

Key Metrics

PE Ratio
(x)
-15.39
EPS - TTM
(₹)
-2.34
MCap
(₹ Cr.)
24.56
Sectoral MCap Rank
155
PB Ratio
(x)
2.76
Div Yield
(%)
0.00
Face Value
(₹)
10.00
Beta

Beta

1 Month0.12
3 Months0.34
6 Months0.09
1 Year0.11
3 Years-0.12

0.12
VWAP
(₹)
32.17
52W H/L
(₹)
61.95 / 23.60

Phaarmasia share price insights

View All
  • Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

  • Company has posted a profit of Rs 0.27 cr in Jun 30, 2025 quarter after 3 consecutive quarter of losses. (Source: Standalone Financials)

  • Sales de-grew by 19.64%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 7.84% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Phaarmasia Ltd. share price moved up by 1.83% from its previous close of Rs 35.33. Phaarmasia Ltd. stock last traded price is 35.98

    Share PriceValue
    Today/Current/Last-35.98
    Previous Day-35.33

InsightsPhaarmasia

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Phaarmasia Ltd Share Price Returns

    1 Day1.83%
    1 Week15.25%
    1 Month-9.82%
    3 Months5.82%
    1 Year-36.52%
    3 Years38.38%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Phaarmasia Ltd belongs to analysts' top-rated companies list?

    View Stock Screeners

    Phaarmasia Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Phaarmasia Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Phaarmasia Financials

    • Insights

      • PAT: Entering the Green

        Company has posted a profit of Rs 0.27 cr in Jun 30, 2025 quarter after 3 consecutive quarter of losses. (Source: Standalone Financials)
      • Topline Contraction

        Sales de-grew by 19.64%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)
      QuarterlyJun 2023
      Total Income7.02
      Total Income Growth (%)-
      Total Expenses7.28
      Total Expenses Growth (%)-
      EBIT-0.26
      EBIT Growth (%)-
      Profit after Tax (PAT)-0.27
      PAT Growth (%)-
      EBIT Margin (%)-3.72
      Net Profit Margin (%)-3.78
      Basic EPS (₹)-0.39
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income7.195.614.916.158.44
      Total Income Growth (%)28.0414.32-20.14-27.13-17.13
      Total Expenses6.856.135.606.798.19
      Total Expenses Growth (%)11.809.45-17.60-17.03-15.97
      EBIT0.34-0.51-0.69-0.640.25
      EBIT Growth (%)----354.60-42.70
      Profit after Tax (PAT)0.27-0.53-0.70-0.640.28
      PAT Growth (%)----332.09-41.61
      EBIT Margin (%)4.73-9.11-13.96-10.452.99
      Net Profit Margin (%)3.76-9.35-14.24-10.433.28
      Basic EPS (₹)0.40-0.77-1.02-0.940.40
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue25.1231.2528.0117.6920.79
      Total Revenue Growth (%)-19.6411.6058.35-14.93-16.95
      Total Expenses26.7231.8029.4419.2520.31
      Total Expenses Growth (%)-15.988.0352.94-5.23-15.62
      Profit after Tax (PAT)-1.59-0.52-1.26-1.550.31
      PAT Growth (%)----595.91-42.20
      Operating Profit Margin (%)-6.51-1.64-5.04-9.042.46
      Net Profit Margin (%)-6.52-1.69-4.58-8.981.56
      Basic EPS (₹)2.33-0.76-1.84-2.270.46

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets21.5631.4528.4221.2121.91
      Total Assets Growth (%)-31.4510.6633.99-3.19-34.79
      Total Liabilities12.8221.1517.619.158.26
      Total Liabilities Growth (%)-39.3920.1092.4610.77-59.09
      Total Equity8.7410.3010.8112.0613.65
      Total Equity Growth (%)-15.15-4.72-10.36-11.651.79
      Current Ratio (x)0.650.860.870.941.09
      Total Debt to Equity (x)0.000.000.000.000.01
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

      No reported Balance Sheet are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities0.000.110.65-0.170.25
      Net Cash used in Investing Activities-0.120.00-0.01--
      Net Cash flow from Financing Activities-0.15-0.16-0.161,104.00-0.02
      Net Cash Flow-0.27-0.060.48-0.170.23
      Closing Cash & Cash Equivalent0.360.630.690.220.38
      Closing Cash & Cash Equivalent Growth (%)-42.54-8.20220.90-43.76149.10
      Total Debt/ CFO (x)0.000.000.01-0.170.20

      All figures in Rs Cr, unless mentioned otherwise

      No reported Cash Flow Statement are available.

    • Insights

      • Losing Shareholder's Money

        Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)-18.19-8.55-19.16-19.783.31
      Return on Capital Employed (%)-17.72-4.76-12.45-12.613.49
      Return on Assets (%)-7.37-1.64-4.43-7.291.42
      Interest Coverage Ratio (x)-80.17-3.60-23.09-294.2771.19
      Asset Turnover Ratio (x)0.921.021.110.800.72
      Price to Earnings (x)-12.59-38.46-12.69-13.6654.64
      Price to Book (x)2.293.282.432.701.80
      EV/EBITDA (x)-15.51-121.65-14.88-16.5520.00
      EBITDA Margin (%)-5.19-0.51-3.73-7.354.18

      No reported Financial Ratios are available.

    Financial InsightsPhaarmasia

    • Income (P&L)
    • Ratios
      • PAT: Entering the Green

        Company has posted a profit of Rs 0.27 cr in Jun 30, 2025 quarter after 3 consecutive quarter of losses. (Source: Standalone Financials)

      • Topline Contraction

        Sales de-grew by 19.64%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Standalone Financials)

      • Losing Shareholder's Money

        Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Phaarmasia Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Phaarmasia Ltd Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Phaarmasia Ltd-15.392.81-18.19-17.72-7.3712.27-6.51-6.522.330.650.000.00
      Gujarat Terce-37.795.51-15.1037.36-4.287.617.58-1.94-1.320.950.150.31
      Rubra Medica378.4460.664.558.583.89-36.799.585.080.056.920.000.00
      Bacil Pharma21.870.951.581.601.57123.820.000.000.6417.640.010.41
      Ishita Drugs21.392.038.0411.265.322.578.185.782.902.770.36-1.07
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Zenith Health
      • Zenlabs Ethica
      • Chemo Pharma
      • Norris Medicine
      • Parmax Pharma

      Choose from Stocks

      Peers InsightsPhaarmasia

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Phaarmasia Shareholding Pattern

        • Loading...
          Showing Phaarmasia Shareholding as on Jun 2025
          CategoryJun 2025Mar 2025Dec 2024Sep 2024
          Promoters73.5173.5173.5173.51
          Pledge0.000.000.000.00
          FII0.000.000.000.00
          DII0.000.000.000.00
          Mutual Funds0.000.000.000.00
          Others26.4826.4826.4826.48
        • Showing Shareholding as on Jun 2025
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters50,18,73273.51 %0.00
          Pledge00.00 %0.00
          Others18,08,22826.48 %0.00

        Phaarmasia MF Ownership

        MF Ownership details are not available.

        Phaarmasia Corporate Actions

        • Meeting DateAnnounced onPurposeDetails
          Oct 14, 2025Sep 15, 2025POM-
          Sep 25, 2025Sep 03, 2025AGM-
          Aug 11, 2025Aug 07, 2025Board MeetingQuarterly Results
          May 28, 2025May 23, 2025Board MeetingAudited Results
          Feb 14, 2025Feb 11, 2025Board MeetingQuarterly Results
        • Dividend announcements are not available.

        • All TypesEx-DateRecord DateAnnounced onDetails
          RightsMay 14, 1994Jun 07, 1994May 04, 1994Rights ratio: 1 share for every 1 held at a price of Rs 10.0

        About Phaarmasia

        Phaarmasia Ltd., incorporated in the year 1981, is a Small Cap company (having a market cap of Rs 24.56 Crore) operating in Pharmaceuticals sector. Phaarmasia Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2024. Show More

        • Executives

        • Auditors

        • NB

          Naga Bhaskara Rao Yallapragada

          Whole Time Director
          MR

          Maneesh Ramakant Sapte

          Non Executive Director
          RV

          Rashmi Vinay Sapte

          Non Executive Director
          VR

          Vinay Ramakant Sapte

          Non Executive Director
          Show More
        • Sathuluri & Co.

        FAQs about Phaarmasia share

        • 1. What is Phaarmasia Ltd share price and what are the returns for Phaarmasia Ltd share?
          Phaarmasia Ltd share price is Rs 35.98 as on 17 Oct, 2025, 03:44 PM IST. Phaarmasia Ltd share price is up by 1.83% based on previous share price of Rs. 32.7.
        • 2. What has been highest price of Phaarmasia Ltd share in last 52 weeks?
          Phaarmasia Ltd share price saw a 52 week high of Rs 61.95 and 52 week low of Rs 23.60.
        • 3. What's the market capitalization of Phaarmasia Ltd?
          Market Capitalization of Phaarmasia Ltd stock is Rs 24.56 Cr.
        • 4. What is the PE & PB ratio of Phaarmasia Ltd?
          The PE ratio of Phaarmasia Ltd stands at -15.12, while the PB ratio is 2.76.
        • 5. What are the returns for Phaarmasia Ltd share?
          Return Performance of Phaarmasia Ltd Shares:
          • 1 Week: Phaarmasia Ltd share price moved up by 15.25%
          • 6 Month: Phaarmasia Ltd share price moved up by 28.18%

        Trending in Markets

        Top Gainers As on 03:59 PM | 17 Oct 2025

        Whirlpool India1,384.40
        146.61 (11.85%)
        Bombay Burmah1,999.70
        112.00 (5.94%)
        Adani Power165.98
        8.61 (5.48%)
        SBFC Finance112.83
        4.93 (4.56%)
        Delhivery465.35
        18.56 (4.16%)

        Top Losers As on 03:58 PM | 17 Oct 2025

        CreditAccess Grameen1,288.90
        -103.50 (-7.44%)
        SterlingWilson Solar226.47
        -16.60 (-6.83%)
        Jindal Saw190.64
        -10.65 (-5.29%)
        Wipro240.90
        -12.91 (-5.09%)
        Tanla Platforms674.55
        -33.16 (-4.69%)

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times